144 related articles for article (PubMed ID: 8772089)
1. [Hemodynamic disorders due to liver cirrhosis].
Garbuzenko DV
Klin Med (Mosk); 1996; 74(2):5-7. PubMed ID: 8772089
[No Abstract] [Full Text] [Related]
2. [Medical therapy of portal hypertension due to liver cirrhosis].
Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic changes and its significance after liver transplantation for cirrhosis and portal hypertension].
Zhang TL
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1689-92. PubMed ID: 19094724
[No Abstract] [Full Text] [Related]
4. Hemodynamics in the isolated cirrhotic liver.
Zipprich A
J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
6. [Echographic and hemodynamic indicators in liver cirrhosis with portal hypertension].
Rikhsieva LE; Akhmedzhanova ShSh; Miasnik BN
Sov Med; 1989; (2):13-5. PubMed ID: 2658117
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
8. [Functional factors which contribute to portal hypertension in hepatic cirrhosis].
Orrego Matte H
Medicina (B Aires); 1970; 30(4):399-401. PubMed ID: 5487697
[No Abstract] [Full Text] [Related]
9. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
[TBL] [Abstract][Full Text] [Related]
10. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
Gatta A; Bolognesi M; Sacerdoti D; Merkel C
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
[TBL] [Abstract][Full Text] [Related]
11. [Physiopathological bases of the medical treatment of portal hypertension].
Cuccurullo F; Seccia G; Porreca E; Guglielmi MD; Mezzetti A; Tomassetti V; Marzio L
G Clin Med; 1982 Oct; 63(10):737-43. PubMed ID: 7182198
[No Abstract] [Full Text] [Related]
12. [Vasodilators and renal function in cirrhosis].
Albillos A; Iborra J
Gastroenterol Hepatol; 1995 Nov; 18(9):488-92. PubMed ID: 8521230
[No Abstract] [Full Text] [Related]
13. Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis.
Møller S
Dan Med Bull; 1998 Feb; 45(1):1-14. PubMed ID: 9504263
[No Abstract] [Full Text] [Related]
14. [Vasodilator agents in portal hypertension].
Combis JM; Vinel JP
Gastroenterol Clin Biol; 1991; 15(12):881-7. PubMed ID: 1686004
[No Abstract] [Full Text] [Related]
15. Splanchnic and systemic vasodilatation: the patient.
Tsai MH
J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
[TBL] [Abstract][Full Text] [Related]
16. [Liver cirrhosis and the renin-angiotensin-aldosterone system].
Lozano de León F; Leal M; Lissen E
Rev Esp Enferm Apar Dig; 1986 Nov; 70(5):465-8. PubMed ID: 3797771
[No Abstract] [Full Text] [Related]
17. Pharmacological treatment of portal hypertension.
González-Abraldes J; Bosch J; García-Pagán JC
Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
[TBL] [Abstract][Full Text] [Related]
18. Does losartan work after all?
Blendis LM; Wong F
Am J Gastroenterol; 2003 Jun; 98(6):1222-4. PubMed ID: 12818261
[No Abstract] [Full Text] [Related]
19. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
[No Abstract] [Full Text] [Related]
20. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
Schneider AW; Kalk JF; Klein CP
Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
